Engineered nanoparticles for imaging and targeted drug delivery in hepatocellular carcinoma
Abstract Liver cancer, notably hepatocellular carcinoma (HCC), poses a significant global health burden due to its high fatality rates. Conventional antitumor medications face challenges, including poor targeting, high toxicity, and drug resistance, leading to suboptimal clinical outcomes. This revi...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-04-01
|
| Series: | Experimental Hematology & Oncology |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s40164-025-00658-z |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850203992299143168 |
|---|---|
| author | Xianzhe Yu Qin Zhang Leibo Wang Yan Zhang Lingling Zhu |
| author_facet | Xianzhe Yu Qin Zhang Leibo Wang Yan Zhang Lingling Zhu |
| author_sort | Xianzhe Yu |
| collection | DOAJ |
| description | Abstract Liver cancer, notably hepatocellular carcinoma (HCC), poses a significant global health burden due to its high fatality rates. Conventional antitumor medications face challenges, including poor targeting, high toxicity, and drug resistance, leading to suboptimal clinical outcomes. This review focused on nanoparticle use in diagnosing and delivering medication for HCC, aiming to advance the development of nanomedicines for improved treatment outcomes. As an emerging frontier science and technology, nanotechnology has shown great potential, especially in precision medicine and personalized treatment. The success of nanosystems is attributable to their smaller size, biocompatibility, selective tumor accumulation, and lower toxicity. Nanoparticles, as a central part of nanotechnology innovation, have emerged in the field of medical diagnostics and therapeutics to overcome the various limitations of conventional chemotherapy, thus offering promising applications for improved selectivity, earlier and more precise diagnosis of cancers, personalized treatment, and overcoming drug resistance. Nanoparticles play a crucial role in drug delivery and imaging of HCC, with the body acting as a delivery system to target and deliver drugs or diagnostic reagents to specific organs or tissues, helping to accurately diagnose and target therapies while minimizing damage to healthy tissues. They protect drugs from early degradation and increase their biological half-life. |
| format | Article |
| id | doaj-art-873f0864951245519d9c19d4285aeb14 |
| institution | OA Journals |
| issn | 2162-3619 |
| language | English |
| publishDate | 2025-04-01 |
| publisher | BMC |
| record_format | Article |
| series | Experimental Hematology & Oncology |
| spelling | doaj-art-873f0864951245519d9c19d4285aeb142025-08-20T02:11:22ZengBMCExperimental Hematology & Oncology2162-36192025-04-0114111810.1186/s40164-025-00658-zEngineered nanoparticles for imaging and targeted drug delivery in hepatocellular carcinomaXianzhe Yu0Qin Zhang1Leibo Wang2Yan Zhang3Lingling Zhu4Department of Medical Oncology, Cancer Center & Lung Cancer Center/Lung Cancer Institute, West China Hospital, Sichuan UniversityDepartment of Postgraduate Students, West China School of Medicine/West China Hospital, Sichuan UniversityDepartment of Surgery, Beijing Jishuitan Hospital Guizhou Hospital GuiyangDepartment of Medical Oncology, Cancer Center & Lung Cancer Center/Lung Cancer Institute, West China Hospital, Sichuan UniversityDepartment of Medical Oncology, Cancer Center & Lung Cancer Center/Lung Cancer Institute, West China Hospital, Sichuan UniversityAbstract Liver cancer, notably hepatocellular carcinoma (HCC), poses a significant global health burden due to its high fatality rates. Conventional antitumor medications face challenges, including poor targeting, high toxicity, and drug resistance, leading to suboptimal clinical outcomes. This review focused on nanoparticle use in diagnosing and delivering medication for HCC, aiming to advance the development of nanomedicines for improved treatment outcomes. As an emerging frontier science and technology, nanotechnology has shown great potential, especially in precision medicine and personalized treatment. The success of nanosystems is attributable to their smaller size, biocompatibility, selective tumor accumulation, and lower toxicity. Nanoparticles, as a central part of nanotechnology innovation, have emerged in the field of medical diagnostics and therapeutics to overcome the various limitations of conventional chemotherapy, thus offering promising applications for improved selectivity, earlier and more precise diagnosis of cancers, personalized treatment, and overcoming drug resistance. Nanoparticles play a crucial role in drug delivery and imaging of HCC, with the body acting as a delivery system to target and deliver drugs or diagnostic reagents to specific organs or tissues, helping to accurately diagnose and target therapies while minimizing damage to healthy tissues. They protect drugs from early degradation and increase their biological half-life.https://doi.org/10.1186/s40164-025-00658-zHepatocellular carcinomaNanomedicineNanoparticlesDrug deliveryTumor imagingEarly diagnosis |
| spellingShingle | Xianzhe Yu Qin Zhang Leibo Wang Yan Zhang Lingling Zhu Engineered nanoparticles for imaging and targeted drug delivery in hepatocellular carcinoma Experimental Hematology & Oncology Hepatocellular carcinoma Nanomedicine Nanoparticles Drug delivery Tumor imaging Early diagnosis |
| title | Engineered nanoparticles for imaging and targeted drug delivery in hepatocellular carcinoma |
| title_full | Engineered nanoparticles for imaging and targeted drug delivery in hepatocellular carcinoma |
| title_fullStr | Engineered nanoparticles for imaging and targeted drug delivery in hepatocellular carcinoma |
| title_full_unstemmed | Engineered nanoparticles for imaging and targeted drug delivery in hepatocellular carcinoma |
| title_short | Engineered nanoparticles for imaging and targeted drug delivery in hepatocellular carcinoma |
| title_sort | engineered nanoparticles for imaging and targeted drug delivery in hepatocellular carcinoma |
| topic | Hepatocellular carcinoma Nanomedicine Nanoparticles Drug delivery Tumor imaging Early diagnosis |
| url | https://doi.org/10.1186/s40164-025-00658-z |
| work_keys_str_mv | AT xianzheyu engineerednanoparticlesforimagingandtargeteddrugdeliveryinhepatocellularcarcinoma AT qinzhang engineerednanoparticlesforimagingandtargeteddrugdeliveryinhepatocellularcarcinoma AT leibowang engineerednanoparticlesforimagingandtargeteddrugdeliveryinhepatocellularcarcinoma AT yanzhang engineerednanoparticlesforimagingandtargeteddrugdeliveryinhepatocellularcarcinoma AT linglingzhu engineerednanoparticlesforimagingandtargeteddrugdeliveryinhepatocellularcarcinoma |